PUBLIC COMPANY
saveGenetix Biotherapeutics Inc
updated 3mo ago
community read0 votes
pipeline
3
marketed
2
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(3)
pipeline depth3 products
1Phase 32Marketed
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- —Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product
- —A Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcel
- —Long-term Follow-up of Subjects With Transfusion-Dependent β-Thalassemia (TDT) Treated With Ex Vivo Gene Therapy
- —Long-term Follow-up of Subjects with Sickle Cell Disease Treated with Ex Vivo Gene Therapy
- phase2A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease
- —A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel
- phase3A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Disease
- phase3A Clinical Study to Assess the Efficacy and Safety of Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy (CALD)
🐶 Hiring Signal
News
- Beam’s base editing therapy for sickle cell hits goal in pivotal trialThe result represents a scientific milestone and positions Beam to submit a first-of-its-kind FDA application as soon as the end of the year.biopharma_dive · 4d ago
- Beam preps FDA run for industry-first base-edited therapy after pivotal sickle cell successBeam Therapeutics' risto-cel provided at least 12 consecutive months of freedom from severe pain crises for patients with sickle cell disease in a mid-stage trial, setting the stage for an FDA appl…biospace · 4d ago
- Beam’s sickle cell therapy results tee up potential Casgevy, Lyfgenia showdownGearing up for a potential FDA filing by the end of the year, Beam Therapeutics revealed results from a phase 1/2 study of its base-edited cell therapy risto-cel, showing the potential sickle cell…fiercebiotech · 4d ago
comments(0)
5-min edit window · permanent after that